Healthcare (Mental Health)

HR 5357, the College Students Continuation of Mental Health Care Act of 2025, allows college mental health providers to offer telehealth services to enrolled or recently attending students across state lines. It directly affects college mental health providers (employed by institutions of higher education) and students registered at or who attended the college within the past three months. Key provisions require providers to verify student identity, obtain consent for telehealth, maintain backup communication methods, and respect state prohibitions on specific services while operating under their home state’s licensing rules. The bill also clarifies that malpractice insurance covers these telehealth services as if provided in the provider’s home state and permits states to form compacts to facilitate cross-state telehealth.

HR 3655, the STAR Plus Scholarship Act, creates a federal scholarship program to address shortages in mental health and substance use disorder treatment workforces. It provides tuition and educational expense coverage to students enrolled in approved programs leading to careers as psychiatrists, social workers, addiction counselors, or other mental health professionals. In exchange, recipients must work full-time in designated mental health professional shortage areas or counties with high overdose death rates for one year per scholarship year. The program authorizes $75 million annually (2026-2030) and prioritizes applicants from underrepresented groups or those likely to continue serving in shortage areas after their obligation ends.

This bill requires the Department of Veterans Affairs (VA) to establish clear standards for evaluating all VA suicide prevention and mental health grant or pilot programs. It mandates that these programs set measurable goals, develop detailed evaluation plans (including data collection methods and analysis), and share results with relevant stakeholders before, during, and after implementation. The VA must also conduct post-program evaluations to assess effectiveness and share "best practices" across programs. These standards apply to all existing and future VA programs focused on veteran mental health, ensuring consistent evaluation and transparency. The bill directly affects how the VA administers suicide prevention initiatives for veterans.

HR 3027, the Green Star Families Act, establishes a free counseling program for the next of kin (like spouses, children, or parents) and former volunteer caregivers who provided unpaid care for at least three months to veterans who died by suicide. The bill requires the Department of Veterans Affairs to provide counseling services that are reasonably accessible and comparable to existing VA services, potentially partnering with state or private organizations. It mandates that the VA implement this program within 90 days of the bill's enactment. The law directly affects veterans' families and unpaid caregivers who lose a veteran to suicide, offering them accessible mental health support through the VA system.

HR 3316, the Stop Mental Health Stigma in Our Communities Act of 2025, requires the HHS Secretary to develop a national outreach strategy and conduct two systematic reviews targeting mental health disparities in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) communities. The strategy mandates culturally tailored materials to reduce stigma, increase awareness of mental health services, and engage community members, funded at $3 million annually from 2026-2030. It also directs a year-long review of AANHPI youth mental health crises (including suicide rates) and a review of AANHPI behavioral health workforce shortages, both requiring disaggregated data reporting. The bill directly affects AANHPI individuals - particularly youth and underserved subgroups - by mandating federal action to address systemic barriers like language gaps and underrepresentation in care.

The RETAIN Act creates a refundable tax credit for early childhood educators, teachers, school leaders, and mental health providers working in high-need schools or early childhood programs. The credit pays $5,800 to $11,600 annually based on continuous years of service (e.g., $5,800 for years 1-2, $11,600 for year 10), increasing with experience to address low pay and retention challenges. It directly affects educators in public elementary/secondary schools serving high-poverty communities and early childhood programs meeting specific quality standards. The credit supplements existing pay but cannot reduce state/local compensation or loan forgiveness programs for eligible workers.

This bill requires every Department of Veterans Affairs (VA) hospital and urgent care facility to employ at least one Sexual Assault Nurse Examiner (SANE) or a qualified healthcare provider to perform sexual assault forensic examinations. It mandates that after such an examination, veterans must be verbally referred to mental health services, either at the VA hospital or via a Veterans Care Agreement if VA wait times exceed 30 days. The bill explicitly prohibits any reduction in other patient care responsibilities for VA staff while implementing these requirements. The law directly affects veterans seeking sexual assault care at VA facilities by ensuring access to specialized examiners and timely mental health referrals.

HR 3566, the ANCHOR for Military Families Act, requires the Department of Defense to provide military members and their families with comprehensive relocation assistance information at least 45 days before a permanent change of station. The bill mandates that this information cover educational resources for children (including school transitions, special education, and Individualized Education Programs), housing options, mental health support, spouse employment assistance, and legal/financial counseling. It directs the Secretary of Defense to integrate these details into accessible briefings, online resources, and materials at military installations. The law also requires annual reports to Congress on implementation progress and family awareness of available support programs. This bill directly affects active-duty service members and their families facing relocation due to military orders.

The STRONG Support for Children Act of 2025 establishes a federal grant program to help communities prevent and mitigate childhood trauma through data analysis and trauma-informed care coordination. It authorizes up to $47.5 million in funding to support up to 5 eligible entities (like state or local health departments) to identify geographic areas with high rates of adverse childhood experiences and connect children and families with services including mental health support, housing assistance, substance use treatment, and economic resources. The bill requires grantees to use culturally specific, gender-responsive approaches and prohibits using data for individual case decisions or requiring participation in services. The program will be evaluated over 7 years to assess its impact on reducing childhood trauma and improving outcomes like housing stability, school readiness, and reduced foster system involvement.

SUPPORT for Patients and Communities Reauthorization Act of 2025 This act reauthorizes and revises programs and activities relating to addressing substance use disorders, overdoses, and mental health. (For additional information on each section of this act, see CRS Report R48864 .) TITLE I--PREVENTION (Sec. 101) This section reauthorizes through FY2030 Centers for Disease Control and Prevention (CDC) programs that provide information, grants, and technical assistance relating to studying and preventing prenatal and postnatal substance use disorders. (Sec. 102) This section reauthorizes through FY2030 CDC programs that carry out and provide grants for surveillance, treatment, and education relating to infections associated with illicit drug use. (Sec. 103) This section reauthorizes through FY2030 and expands CDC programs that carry out activities and provide grants relating to monitoring drug use and overdoses (e.g., supporting state prescription drug monitoring programs), preventing and responding to substance use disorders, and raising awareness regarding opioids and other substances.  The section authorizes additional activities, including wastewater surveillance and collecting data on risk factors associated with overdoses. (Sec. 104) This section reestablishes, expands, and provides statutory authority for Department of Health and Human Services (HHS) activities addressing fetal alcohol spectrum disorders (i.e., conditions caused by prenatal alcohol exposure), including carrying out and providing grants for research, education and public awareness, and intervention and support services for affected individuals. (Sec. 105) This section specifies that, in providing grants to support state prescription drug monitoring programs, the CDC is not authorized to require states to use specific vendors or interoperability systems other than to align with general, consensus-based standards for interoperability.   (Sec. 106) This section reauthorizes through FY2030 and expands grants to government entities to provide first responders with opioid overdose reversal drugs (e.g., naloxone) and related training. The grant program is administered by the Substance Abuse and Mental Health Services Administration (SAMHSA). The section expands the program to include (1) treatment and training for overdoses from other drugs besides opioids, and (2) treatment with drugs or devices that are legally marketed under applicable law. Current law limits the program to addressing opioid overdoses and to drugs or devices that are officially approved or cleared by the Food and Drug Administration (FDA). (Sec. 107) This section reauthorizes through FY2030 and revises the National Child Traumatic Stress Initiative and related activities, which are administered by SAMHSA. Under the initiative, SAMHSA provides grants and other support to improve the quality of and increase access to services addressing psychological trauma in youth and families.  The section requires grant recipients to develop training and other resources for collaborative implementation of best practices. (Sec. 108) This section requires SAMHSA to undertake efforts to protect the 9-8-8 Suicide & Crisis Lifeline from cybersecurity threats. (The lifeline is a three-digit number that connects callers in suicidal crisis or mental health distress to a national network of crisis centers.) The section includes requirements for the lifeline’s network administrator and participating local and regional crisis centers to report identified cybersecurity incidents and vulnerabilities. The Government Accountability Office must conduct a study that evaluates cybersecurity risks and vulnerabilities associated with the lifeline and report the findings to Congress. (Sec. 109) This section reauthorizes through FY2030 CDC activities to collect and report certain public health data relating to potentially traumatic childhood experiences. (Sec. 110) This section reauthorizes through FY2030 an interdepartmental committee on substance use disorders, establishes an interagency work group on fentanyl contamination of illegal drugs, and expands certain SAMHSA activities to include supporting strategies to raise awareness about the dangers of synthetic opioids for youth. (Sec. 111) This section requires HHS to publish guidance regarding at-home safe drug disposal systems. (Sec. 112) This section requires HHS to publish a plan for assessing approved opioid analgesic drugs (i.e., opioid pain relievers) that addresses the public health effects of these drugs, including updates on actions by the FDA with respect to risk-benefit assessments and supporting development and approval of nonaddictive medical products. HHS must provide an opportunity for public input on the FDA’s regulation of opioid analgesic drugs. (Sec. 113) This section provides statutory authority for SAMHSA’s State Opioid Response and Tribal Opioid Response Grants to be used for facilitating access to drug checking technologies, such as fentanyl and xylazine test strips, to the extent permitted by federal and state law. TITLE II--TREATMENT (Sec. 201) This section reauthorizes through FY2030 the Residential Treatment for Pregnant and Postpartum Women program, which is administered by the Center for Substance Abuse Treatment within SAMHSA. This program awards grants to fund services for pregnant and postpartum women with substance use disorders, including services for treatment, recovery support, and case management.  The section also specifically allows grant recipients to conduct outreach that is targeted at women disproportionately impacted by maternal substance use disorders. (Sec. 202) This section provides statutory authority for the Minority Fellowship Program to include fellowships for training in the field of addiction medicine. The Minority Fellowship Program, administered by SAMHSA, funds fellowships for individuals seeking graduate degrees and planning to work on addressing mental or substance use disorders in racial and ethnic minority populations. (Sec. 203) This section reauthorizes through FY2030 the Behavioral Health Workforce Education and Training Program for Professionals, which is administered by the Health Resources and Services Administration (HRSA). This program provides grants to educational organizations and programs to recruit and educate students in mental and behavioral health. (Sec. 204) This section reauthorizes through FY2030 the Substance Use Disorder Treatment and Recovery Loan Repayment Program, which is administered by HRSA. This program provides repayment of educational loans for health care practitioners who agree to provide direct treatment or recovery support for substance use disorders in certain areas with shortages of health professionals or high rates of overdose. (Sec. 206) This section reauthorizes through FY2030 and expands an interagency task force that must develop recommendations relating to (1) best practices for preventing and mitigating trauma in youth and (2) coordinating the federal response to families impacted by substance use disorders and other trauma. (Sec. 208) This section requires SAMHSA to conduct a review of how states use funds under the Community Mental Health Services Block Grant program to address first episode psychosis, including the use of evidence-based services for individuals with early serious mental illness and children with serious emotional disturbance. SAMHSA must report to Congress on the findings of the review and update the guidance for the block grant program based on such findings. (Sec. 209) This section requires HHS to review relevant data and, if determined appropriate, request that the Drug Enforcement Administration (DEA) revise the scheduling of approved products containing a combination of buprenorphine and naloxone under the Controlled Substances Act. The DEA must review such requests and determine whether to revise the schedules. (Sec. 210) This section requires that, when HHS issues new regulations or guidance on grant programs addressing opioid use disorders, references to an opioid overdose reversal drug (e.g., naloxone) must broadly include any opioid overdose reversal drug approved by the FDA. Within one year after the act’s enactment, HHS must update all references accordingly in regulations or guidance issued prior to the act’s enactment that are applicable to State Opioid Response Grants, Tribal Opioid Response Grants, or certain other grants relating to substance use disorder prevention. (Sec. 211) This section requires HHS to convene a public roundtable with public and private stakeholders on expanding the use of electronic health records among mental health and substance use disorder service providers. HHS must report to Congress on the results of the roundtable with respect to specified topics. TITLE III--RECOVERY (Sec. 301) This section reauthorizes through FY2030 the Building Communities of Recovery program, which is administered by the Center for Substance Abuse Treatment within SAMHSA. This program provides grants to certain community nonprofit organizations for developing and delivering coordinated community and statewide recovery support services for individuals with substance use disorders. (Sec. 302) This section reauthorizes through FY2030 and expands the National Peer-Run Training and Technical Assistance Center for Addiction Recovery Support, which is administered by SAMHSA. The center provides training and resources to public and private nonprofit entities relating to recovery support services for substance use disorders and co-occurring conditions (i.e., mental health conditions coexisting with substance use disorders). The section expands the center's functions to include professional development of peer support specialists and recovery support services in nonclinical settings. It also authorizes through FY2030 a regional technical assistance center to support the ability of the center to meet a particular region's needs. (Sec. 303) This section reauthorizes through FY2030 grants to nonprofits for establishing or operating opioid recovery centers providing comprehensive treatment and recovery support services. The grant program is administered by SAMHSA. (Sec. 304) This section reauthorizes through FY2030 and revises the Preventing Youth Overdose: Treatment, Recovery, Education, Awareness, and Training (PYO-TREAT) program, which is administered by SAMHSA. The PYO-TREAT program provides grants and other support to educational and public entities for substance use disorder prevention, treatment, and recovery for children and young adults. The section revises the program to provide statutory authority for (1) requiring applicants to submit plans for sustaining activities under the program after the grant has ended, and (2) expanding eligible grant recipients to include consortia of local educational agencies. SAMHSA must report to Congress on the PYO-TREAT program’s effectiveness. (Sec. 305) This section reauthorizes through FY2030 and expands the Treatment, Recovery, and Workforce Support program, which is administered by SAMHSA. This program provides grants to public and private nonprofit entities to support individuals in treatment and recovery for substance use disorders and co-occurring conditions to live independently and participate in the workforce. The section authorizes using 5% of such grant funds for transportation services and requires grant recipients to report on the employment and earnings outcomes of program participants. Also, the section reauthorizes through FY2030 the Recovery Housing Pilot Program, which assists states in providing individuals in recovery from a substance use disorder with stable, temporary housing for up to two years. This program is administered by the Department of Housing and Urban Development. (Sec. 306) This section reauthorizes through FY2030 the Support to Communities: Fostering Opioid Recovery through Workforce Development program, which is administered by the Department of Labor. This program provides grants to public entities to address the economic and workforce-related impacts of substance use disorders through activities such as screening and support services, training, and engaging with employers. (Sec. 307) This section requires HHS to convene a public meeting relating to improving awareness of and access to grants provided by SAMHSA. Based on the stakeholder feedback received at the meeting, HHS must implement improvements to relevant websites and report to Congress. TITLE IV--MISCELLANEOUS MATTERS (Sec. 401) This section allows pharmacies to deliver to prescribing practitioners schedule III-V controlled substances that are not directly administered by the practitioner (i.e., self-administered), provided the controlled substances are subject to a risk evaluation and mitigation strategy to assure safe use by the patient, including post-administration monitoring by a health care provider.  (Sec. 402) This section expands the types of organizations that may provide training or education required for practitioners registering with the DEA to dispense (i.e., prescribe or administer) schedule II-V controlled substances. This section applies retroactively, taking effect as if enacted on December 29, 2022.